Advertisement.

ATAI Projected Dividend Yield

Ord/ATAI Life Sciences NV ( NASDAQ : ATAI )

ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company developing treatments for mental health disorders. Its lead compounds include PCN-101, a subcutaneous R-ketamine for treatment-resistant depression; RL-007, a modulator for cognitive impairment in schizophrenia; DMX-1002, an oral ibogaine for opioid use disorder; GRX-917, an oral deuterated etifoxine for generalized anxiety disorder; and NN-101, an intranasal N-acetylcysteine for mild traumatic brain injuries. Other candidates include VLS-01 for depression and EMP-01 for PTSD.

23 YEAR PERFORMANCE RESULTS

ATAI Dividend History Detail
ATAI Dividend News
ATAI Competitors News

# of Shares: 0

Closing Price: 1.36

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2011	0.41	0%	0	$ 0.00	0.00%
2012	0.15	0%	0	$ 0.00	0.00%
2013	0.00	0%	0	$ 0.00	0.00%
2014	0.39	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.39	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000